PET-Based Volumetric Biomarkers for Risk Stratification of Non-Small Cell Lung Cancer Patients
Despite the recent advances in lung cancer biology, molecular pathology, and treatment, this malignancy remains the leading cause of cancer-related death worldwide and non-small cell lung cancer (NSCLC) is the most common form found at diagnosis. Accurate staging of the disease is a fundamental prog...
Main Authors: | Sara Pellegrino, Rosa Fonti, Alessandro Pulcrano, Silvana Del Vecchio |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-01-01
|
Series: | Diagnostics |
Subjects: | |
Online Access: | https://www.mdpi.com/2075-4418/11/2/210 |
Similar Items
-
Assessment of mediastinal tumors using SUVmax and volumetric parameters on FDG PET/CT
by: Takahiro Morita, et al.
Published: (2017-01-01) -
Brain Metastases Unresponsive to Immunotherapy Detected by 18F-FDG-PET/CT in a Patient with Melanoma
by: Rosa Fonti, et al.
Published: (2020-06-01) -
Prognostic Significance of Volumetric Parameters Based on FDG PET/CT in Patients with Lung Adenocarcinoma Undergoing Curative Surgery
by: Hyunjong Lee, et al.
Published: (2023-09-01) -
The Role of the Metabolic Parameters of 18F-FDG PET/CT in Patients With Locally Advanced Cervical Cancer
by: Dunhuang Wang, et al.
Published: (2021-08-01) -
Comments on “dynamic 18F‐FDG PET/CT can predict the major pathological response to neoadjuvant immunotherapy in non‐small cell lung cancer”
by: Shan‐Ying Wang, et al.
Published: (2022-12-01)